The FDA denied approval of the much anticipated Merck & Co. cholesterol drug Cordaptive on Monday, stating that more information on the drug is needed, and that the trade name Cordaptive is not acceptable. Merck is also the creator of the controversial cholesterol drug Vytorin, which came under fire in January when studies showed that ...